Open AccessPrognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer
Author(s) -
Wen Feng,
Yuan Li,
Lei Shen,
Xu Cai,
Zheng Zhu,
Jian Chang,
Jingyuan Xiang,
Ya Wei Zhang,
Hai Quan Chen,
Xiao Fu
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6979
Subject(s) - medicine , lung cancer , oncology , stage (stratigraphy) , tumor infiltrating lymphocytes , cancer , immunotherapy , paleontology , biology
The patient prognosis after complete resection for pathologic stage IIIA(N2) non-small cell lung cancer (NSCLC) remains a significant concern. The clinical relevance of the host immune response to NSCLC has yet to be established. We aimed to investigate the prognostic value of tumor-infiltrating lymphocytes (TILs) in a uniform cohort of patients with completely resected stage IIIA(N2) NSCLC.